North America Intrauterine Contraceptive Devices Market, By Type (Hormonal Intrauterine Device, Copper Intrauterine Device), End User (Hospitals, Gynecology Clinics, Community Health Care Centers, Other), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel and NGOs, Others), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2028North America Intrauterine Contraceptive Devices Market, By Type (Hormonal Intrauterine Device, Copper Intrauterine Device), End User (Hospitals, Gynecology Clinics, Community Health Care Centers, Other), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel and NGOs, Others), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2028
Market Analysis and Insights: North America Intrauterine Contraceptive Devices Market
North America intrauterine contraceptive devices market is expected to witness market growth at a rate of 7.15% in the forecast period of 2021 to 2028. Data Bridge Market Research report on North America intrauterine contraceptive devices market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in healthcare sector globally is escalating the growth of North America intrauterine contraceptive devices market.
The Intrauterine contraceptive device (IUCD) refers to a long-acting T-shaped device and reversible placed into the uterus for purposes of contraception. The device assists in preventing fertilization and pregnancy of the eggs in the uterus. IUCDs could be able to use the pills of contraception and are not interfering in sexual intercourse or breastfeeding.
The increase in need for controlling population across the region acts as one of the major factors driving the growth of intrauterine contraceptive devices market. The rise in rate of unplanned pregnancies, especially in young females, and rise in popularity of IUCD as they provide several advantages such as fewer side effects over oral contraception accelerate the market growth. The progress in contraception technology in female contraception drugs and devices, and surge in initiatives by governments and NGOs to promote contraceptives further influence the market. Additionally, increase in unplanned pregnancy rate, development in the healthcare infrastructure, prevalence of sexually-transmitted diseases, and initiatives by governments and NGOs to promote contraceptives positively affects the intrauterine contraceptive devices market. Furthermore, technological innovations leading to effective contraception and fewer side effects extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the treatment, and threat of ectopic pregnancy are expected to obstruct the market growth. The risks of inflammatory pelvic infection (PFD) are projected to challenge the intrauterine contraceptive devices market in the forecast period of 2021-2028.
This North America intrauterine contraceptive devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on North America intrauterine contraceptive devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
North America Intrauterine Contraceptive Devices Market Scope and Market Size
The North America intrauterine contraceptive devices market is segmented on the basis of type, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the intrauterine contraceptive devices market is segmented into hormonal intrauterine device and copper intrauterine device.
- On the basis of end user, the intrauterine contraceptive devices market is segmented into hospitals, gynecology clinics, community health care centers and other.
- On the basis of distribution channel, the intrauterine contraceptive devices market is segmented into hospital pharmacy, retail pharmacy, clinics, online channel, public channel and NGOs and others.
North America Intrauterine Contraceptive Devices Market Country Level Analysis
The North America intrauterine contraceptive devices market is analyzed and market size insights and trends are provided by country, type, end user and distribution channel as referenced above.
The countries covered in the North America intrauterine contraceptive devices market report are U.S., Canada and Mexico in North America.
U.S. dominates the North America intrauterine contraceptive devices market due to the advanced healthcare sector within the region. Canada is projected to witness high growth during the forecast period of 2021 to 2028 because of the growth in awareness in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare infrastructure growth installed base and new technology penetration
North America intrauterine contraceptive devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America intrauterine contraceptive devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the North America intrauterine contraceptive devices market. The data is available for historic period 2010-2019.
Competitive Landscape and North America Intrauterine Contraceptive Devices Market Share Analysis
The North America intrauterine contraceptive devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to North America intrauterine contraceptive devices market.
The major players covered in the North America intrauterine contraceptive devices market report are ALLERGAN, Bayer AG, HLL Lifecare Limited, Pfizer Inc., Okamoto Industries,Inc., Teva Pharmaceutical Industries Ltd., Meril Life Sciences Pvt. Ltd., Mona Lisa, Merck Sharp & Dohme Corp., OCON Medical Ltd, and DKT INTERNATIONAL, among other domestic players. Market share data is available for North America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
